Textile artist Jeanne Hewell-Chambers shares how trust, advocacy, and quirky support turned her fears about a wet AMD clinical trial into stable vision and reclaimed independence. Jeanne ...
SOL-X long-term extension trial in wet AMD enrolled the first subject in April 2026 who had successfully completed the two-year SOL-1 trial Subjects who have completed the two-year follow-up in either ...
DENVER -- A sustained-release VEGF inhibitor implant outperformed standard anti-VEGF therapy for maintaining visual acuity in neovascular, or wet, age-related macular degeneration (AMD), showed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results